Oncology PracticeHepatitis screening now for all patients with cancer on therapyAugust 6, 2020Patient & Survivor CareHodgkin LymphomaIndolent LymphomaMantle Cell LymphomaB Cell LymphomaAggressive LymphomasCNS/Brain Cancer
Hematology NewsFDA okays new CAR T therapy, first for mantle cell lymphomaJuly 28, 2020Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsCOVID-19: Experts hasten to head off mental health crisisApril 23, 2020COVID-19 UpdatesMantle Cell LymphomaMixed Topics
Hematology NewsExperts break down latest CAR T-cell advances in lymphomaJanuary 22, 2020B Cell LymphomaCellular TherapyImmuno-oncologyImmunotherapyLymphoma & Plasma Cell DisordersMantle Cell Lymphoma
Hematology NewsLOXO-305: Next-gen BTK inhibitor safe and effective in B-cell malignanciesDecember 20, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell DisordersCLL
Hematology NewsSome MCL patients can safely stop venetoclax-ibrutinib, study suggestsDecember 14, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsKTE-X19 produces highest response rate in MCL subgroupDecember 14, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsOrelabrutinib could be ‘preferred’ BTK inhibitor for MCLDecember 12, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
The clinical impact of new approvals in sickle cell, MCLDecember 6, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersAnemiaPatient & Survivor Care
Hematology NewsSOX11 shows value as diagnostic marker in MCLDecember 4, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsAcalabrutinib may outperform other targeted therapies in MCLDecember 4, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
Hematology NewsFDA approves Brukinsa for relapsed, refractory MCLNovember 15, 2019Mantle Cell LymphomaB Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsSurvival ‘excellent’ after rituximab-bendamustine induction in transplant-eligible MCLNovember 6, 2019Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsASCO to award $50,000 young investigator grant to study MCLOctober 23, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology NewsFollow-up shows favorable results with acalabrutinib in MCLOctober 8, 2019Mantle Cell LymphomaLymphoma & Plasma Cell DisordersB Cell Lymphoma
